The FDA reportedly hired Nina Devlin, EpiPen maker Mylan's head of global communications, to serve as a senior communications adviser in the agency, according to The Hill.
According to sources familiar with the decision, Ms. Devlin was hired Oct. 15 and will report to the FDA's chief of staff.
Her hire comes roughly two months after Mylan finalized a $465 million settlement with federal government over accusations the drugmaker improperly classified EpiPens as a generic drug to overcharge Medicaid.